{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5fa6db4880850a71c9c4bb45/67a3b4e63eadb4f808fdad44?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Barriers To Minority Participation in MS Clinical Trials","description":"<p>In the clinical trials of new MS medications and procedures, why has the participation of racial and ethnic minority individuals been so low? Is it a difficulty with outreach? Are the patient barriers to participation underrecognized and underaddressed? Does historical mistrust of the medical community remain a strong negative? What should clinicians and trial designers do to increase diversity to improve care for all <strong>i</strong>ndividuals with MS?</p><p><br></p><p>Take our&nbsp;<a href=\"https://elit.dkbmed.com/issues/223/test\" rel=\"noopener noreferrer\" target=\"_blank\">post-test</a>&nbsp;to claim CME credits (https://elit.dkbmed.com/issues/223/test)</p><p>Read this podcast's companion newsletter <a href=\"https://elit.dkbmed.com/issues/221\" rel=\"noopener noreferrer\" target=\"_blank\">here</a>. (https://elit.dkbmed.com/issues/221)</p>","author_name":"eMultipleSclerosis Review"}